• Nem Talált Eredményt

JEADV JEADV

N/A
N/A
Protected

Academic year: 2022

Ossza meg "JEADV JEADV"

Copied!
6
0
0

Teljes szövegt

(1)

DISCLAIMER

Th e Publisher, the European Academy of Dermatology and Venereology and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily refl ect those of the Publisher, the European Academy of Dermatology and Venereology and Editors, neither does the publication of advertisements constitute any endorsement by the Publisher, the European Academy of Dermatology and Venereology and Editors of the products advertised.

SUBSCRIPTIONS

Publisher. The Journal of the European Academy of Dermatology and Venereology is published by John Wiley & Sons Ltd, 9600 Garsington Road, Oxford OX4 2DQ, UK. Tel: +44 1865 776868; Fax: +44 1865 714591. Journal of the European Academy of Dermatology and Venereology has a world web site at http://www.

jeadv.com. This journal is available online at Wiley Online Library. Visit wileyonlinelibrary.com to search the articles and register for table of contents e-mail alerts.

Information for Subscribers. The Journal of the European Academy of Dermatology and Venereology is published monthly. Subscription prices for 2017 are: Print and Online: £2946 (UK), €3743 (Europe), US$5433 (The Americas), US$6338 (Rest of World). Prices are exclusive of tax. Asia-Pacific GST, Canadian GST and European VAT will be applied at the appropriate rates. For more information on current tax rates, please go to wileyonlinelibrary.com/tax-vat. The institutional price includes online access to the current and all online back files to January 1st 2013, where available. For other pricing options, including access information and terms and conditions, please visit wileyonlinelibrary.com/access.

Journal Customer Services. For ordering information, claims and any enquiry concerning your journal subscription please go to http://www.wileycustomerhelp.

com/ask or contact your nearest offi ce:

Americas: E-mail: cs-journals@wiley.com; Tel: +1 781 388 8598 or +1 800 835 6770 (toll free in the USA & Canada).

Europe, Middle East and Africa: E-mail: cs-journals@wiley.com; Tel: +44 1865 778315 Asia Pacifi c: E-mail: cs-journals@wiley.com; Tel: +65 6511 8000

Japan: For Japanese speaking support, E-mail: cs-journal@wiley.com; Tel: +65 6511 8010 or Tel (toll-free): +05 316 50 480.

Visit our Online Customer Get-Help: available in 7 languages at http://www.

wileycustomerhelp.com/ask

JEADV

Journal of the European Academy of Dermatology and Venereology

Published on behalf of the European Academy of Dermatology and Venereology Legal Premises: EADV, Via F. Pelli 2, CH 6900 Lugano, Switzerland

Administrative Offi ce: EADV, Avenue General de Gaulle 38, B-1050 Brussels, Belgium Tel: +32 2 650 00 90; Fax: +32 2 650 00 98

Email: offi ce@eadv.org; Web: www.eadv.org VAT no.: BE 476 222 191

For submission instructions, subscription and all other information visit:

www.jeadv.com

Hudson, NY 12534, USA. Tel: +1 518 822-9300, Fax: +1 518 822-9305; E-mail:

psc@periodicals.com.

HINARI. Access to this journal is available free online within institutions in the developing world through the HINARI initiative with the WHO. For information, visit http://www.who.int/hinari/en/.

BUSINESS CORRESPONDENCE

All business correspondence, including orders for off prints (corporatesaleseurope

@wiley.com) and advertising space (kevin.phillips@wiley.com) should be addressed to Journal of the European Academy of Dermatology and Venereology, John Wiley & Sons, 9600 Garsington Road, Oxford OX4 2DQ, UK.

COPYRIGHT AND PHOTOCOPYING

Copyright © 2017 European Academy of Dermatology and Venereology. All rights reserved. No part of this publication (apart from articles marked ‘OnlineOpen’) may be reproduced, stored or transmitted in any form or by any means without the prior permission in writing from the copyright holder. Authorization to copy items for internal and personal use is granted by the copyright holder for libraries and other users  registered with their local Reproduction Rights Organisation (RRO), e.g., Copyright Clearance Center (CCC), 222 Rosewood Drive, Danvers, MA 01923, USA (www.copyright.com), provided the appropriate fee is paid directly to the RRO. Th is consent does not extend to other kinds of copying such as copying for general distribution for advertising or promotional purposes, for creating new collective works or for resale. Special requests should be addressed to Permissions@wiley.com Journal of the European Academy of Dermatology and Venereology accepts articles for  Open Access publication. Please visit http://olabout.wiley.com/WileyCDA/

Section/id-406241.html for further information about OnlineOpen.

ABSTRACTING AND INDEXING

Th e journal is abstracted in Core Journals in Dermatology, Current Contents/

Clinical Medicine, EMBASE, Index Medicus/MEDLINE, Oncology and Information Service, Research Alert and SciSearch.

PRODUCTION INFORMATION

Production Editor. Michael John M. Flores. E-mail: jdv@wiley.com Suppliers. Typeset by Scientifi c Publishing Services (P) Ltd., Chennai, India.

Printed in United Kingdom by Page Bros (Norwich) Ltd.

Paper. Our policy is to use permanent paper from mills that operate a sustainable forestry policy, and which has been manufactured from pulp that is processed using acid-free and

(2)

June 2017 Volume 31, Issue 6

EDITORIAL

919 Occupational skin disease – a major health problem in Europe J. Ring

COMMENTARIES

921 Dyslipidemia in patients with androgenetic alopecia. Statins, fi nasteride or both?

L. Rudnicka, A. Rakowska

923 Medication non‐adherence: the hidden problem in clinical practice R.J. Th orneloe, C.E.M. Griffi ths, L. Cordingley

GUIDELINES

925 2016 European guideline for the management of vulval conditions

W.I. van der Meijden, M.J. Boff a, W.A. ter Harmsel, G. Kirtschig, F.M. Lewis, M. Moyal-Barracco, G.S. Tiplica, J. Sherrard

REVIEW ARTICLES

942 Lipid profi le in patients with androgenetic alopecia: a meta‐analysis M.W. Kim, I.S. Shin, H.S. Yoon, S. Cho, H.S. Park

952 Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review L. Cruddas, D.M. Baker

964 Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria M. Sánchez-Borges, F. Caballero-Fonseca, A. Capriles-Hulett, L. González-Aveledo, M. Maurer

ORIGINAL ARTICLES AND SHORT REPORTS ONCOLOGY

972 Melanomas vs. nevi in high‐risk patients under long‐term monitoring with digital dermatoscopy:

do melanomas and nevi already diff er at baseline?

P. Tschandl, L. Hofmann, C. Fink, H. Kittler, H.A. Haenssle

(3)

978 Increased non‐melanoma skin cancer risk in young patients with infl ammatory bowel disease on immunomodulatory therapy: a retrospective single‐centre cohort study

J. Clowry, J. Sheridan, R. Healy, S. Deady, D. Keegan, K. Byrne, G. Cullen, H. Mulcahy, H. Comber, A.C. Parnell, G. Doherty, A. Lally

986 Spanish version of the Actinic Keratosis Quality of Life questionnaire

I. Alarcon, G.R. Vinding, K.B. Christensen, S. Esmann, J. Malvehy, S. Puig, G.B.E. Jemec

PSORIASIS AND AUTOIMMUNE DISEASE

992 Effi cacy and safety of interleukin‐17 antagonists in patients with plaque psoriasis: a meta‐analysis from phase 3 randomized controlled trials

D. Wu, S.-Y. Hou, S. Zhao, L.-X. Hou, T. Jiao, N.-N. Xu, N. Zhang

1004 Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis

A. Blauvelt, K.A. Papp, H. Sofen, M. Augustin, G. Yosipovitch, N. Katoh, U. Mrowietz, M. Ohtsuki, Y. Poulin, D. Shrom, R. Burge, K. See, L. Mallbris, K.B. Gordon

1014 Evaluation of adherence predictors for the treatment of moderate to severe psoriasis with biologics:

the importance of physician–patient interaction and communication I. Zschocke, C. Ortland, K. Reich

1021 Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry

A. Pérez-Plaza, G. Carretero, C. Ferrandiz, F. Vanaclocha, F.J. GÓmez-García, E. Herrera-Ceballos, P. De la Cueva-Dobao, I. BelinchÓn, J.L. Sánchez-Carazo, M. Alsina, J.L. LÓpez-Estebaranz, M. Ferrán, R. Torrado, J.M. Carrascosa, M. Llamas-Velasco, R. Rivera, R. Jiménez-Puya, I. García-Doval, M.A. Descalzo, Th e Biobadaderm Study Group

AUTOIMMUNE DISEASE

1029 Cold‐associated perniosis of the thighs histopathologically mimicking lupus. Six observations R. Karkouche, C. Bernigaud, J. Fontugne, O. Zehou, G. Bellaud, M. N'Diaye, K. Cherif, P. Wolkenstein, O. Chosidow, N. Ortonne, S. Ingen-Housz-Oro

1033 Neutrophil‐to‐lymphocyte ratio: a biomarker for predicting systemic involvement in adult IgA vasculitis patients

G.R. Nagy, L. Kemény, Z. Bata-Csörgő

ALLERGY AND ECZEMA

1038 Filaggrin loss‐of‐function mutations, atopic dermatitis and risk of actinic keratosis: results from two cross‐sectional studies

Y.M.F. Andersen, A. Egeberg, E. Balslev, C.L.T. Jørgensen, P.B. Szecsi, S. Stender, J. Kaae, A. Linneberg,

G. Gislason, L. Skov, P.M. Elias, J.P. Th yssen

(4)

URTICARIAL/ANGIOEDEMA

1048 Chronic urticaria in the real‐life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non‐interventional multicentre AWARE study

S.F. Th omsen, E.C. Pritzier, C.D. Anderson, N. Vaugelade-Baust, R. Dodge, A.-K. Dahlborn, C. Vestergaard 1056 Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic

idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema M. Maurer, H. Sofen, B. Ortiz, F. Kianifard, S. Gabriel, J.A. Bernstein

PRURITUS

1064 Novel TRPM8 agonist cooling compound against chronic itch: results from a randomized, double‐blind, controlled, pilot study in dry skin

S. Ständer, M. Augustin, D. Roggenkamp, C. Blome, T. Heitkemper, A.C. Worthmann, G. Neufang

VENEREOLOGY AND SEXUAL HEALTH

1069 Assessing fi nasteride‐associated sexual dysfunction using the FAERS database A.K. Gupta, J. Carviel, M.A. MacLeod, N. Shear

LETTERS TO THE EDITOR

e273 Dermoscopy of small‐size basal cell carcinoma: a case–control study

C. Longo, F. Specchio, S. Ribero, V. Coco, A. Kyrgidis, E. Moscarella, M. Ragazzi, K. Peris, G. Argenziano e275 Trichomycosis ( trichobacteriosis ) capitis misdiagnosed as poliosis: the utility of dermoscopy and why it

should always be done

C. Navarrete-Dechent, F. Fich, S. Gonzalez

e276 Infant bald patch: ultrasonographic diagnosis of aplasia cutis congenita T. Hioki, H. Takama, S. Makita, M. Akiyama

e277 Severe osteoarticular involvement in isotretinoin‐triggered acne fulminans: two cases successfully treated with anakinra

T. Oranges, A. Insalaco, A. Diociaiuti, C. Carnevale, R. Strippoli, G. Zambruno, P. Tomà, M. El Hachem e279 Surgical outcomes refl ect the histological types of cutaneous malignant melanoma

L. Roncati, F. Piscioli, T. Pusiol

e280 Response to ‘Surgical outcomes refl ect the histological types of cutaneous malignant melanoma’

F.C. Svedman

e280 Prevalence of amyloid deposits determined by fi ne‐needle aspiration of abdominal fat in patients with psoriasis

P. Chicharro, I. García-Río, P. Rodríguez-Jiménez, A. Pérez-Plaza, S. Pérez-Gala, C. Marrón, E. Daudén

(5)

e281 Th e concept of ‘Fragile Skin’: a case of disease mongering in dermatology?

P. Elsner

e282 Response to ‘Th e concept of fragile skin: a case of disease mongering in dermatology?’

U. Blume-Peytavi, on behalf of all co-authors from the JEADV supplement e283 Capecitabine and adermatoglyphia: trouble in border!

C. Mazza, F. Slimano, L. Visseaux, M.A. Ordan, D. Botsen, F. Grange, O. Bouche

e284 Fast evaluation and monitoring of ingenol mebutate treatment of multiple basal cell carcinomas by in vivo hand‐held refl ectance confocal microscopy

E. Manubens, A. Barreiro, A. Bennassar, S. Podlipnik, N. Moreno, P. Iglesias, J. Malvehy, S. Puig e286 Non‐melanoma skin cancer mortality rising in susceptible Australians

D. Czarnecki

e287 Epidemiological, dermoscopical and pathological evaluation of melanocytic lesions of the buttock in a 5‐year period:

a female prevalence

G. Paolino, I. Zalaudek, A. Carbone, P. Frascione, M. Donati, C. Panetta, P. Donati e289 Crusted impetigo‐like lesion on the face: a case of IgG/IgA pemphigus

R. Moriuchi, T. Ito, K. Kikuchi, N. Nakashita, R. Muramatsu, K. Natsuga, H. Shimizu, S. Shimizu e291 Tetracyclines and/or nicotinamide in blistering dermatosis

A. Abdelmaksoud

e291 Disseminated cobblestone‐like skin lumps in a newborn

Z.X. Ren, H.Q. Jiang, L.X. Zhang, Q.D. Deng, J.Y. Zhang, X.P. Mu, J. Yang e293 Nympho‐hymenal tear: a distinctive entity?

G.H. Nguyen, N. Lang, S. Lautenschlager

e294 Sunbed use among Portuguese beach goers: a crave group while waiting sunbeds to be abolished A.F. Duarte, J.N. Maia Silva, A. Costa Pereira, E. Nagore, A. Picoto, O. Correia

e296 Th e old reliables outperform new media in social marketing of Euromelanoma in Ireland L. Roche, C.C. Foley, S. McCarthy, M. Murphy

e297 Sites of recurrence in patients following clearance of psoriasis with biologic therapy D.J. No, M. Amin, S.P. Reddy, A. Egeberg, J.J. Wu

e298 Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab: the MARCOPOLO study

S.W. Youn, B.R. Kim, S. Cho, S.J. Seo, E.S. Lee, J.Y. Roh, G.S. Choi, M.G. Lee, on behalf of the MARCOPOLO investigators e299 Monitoring structural changes in Demodex mites under topical Ivermectin in rosacea by means of refl ectance confocal

microscopy: a case series

C. Ruini, E. Sattler, D. Hartmann, M. Reinholz, T. Ruzicka, T. von Braunmühl

e301 Assessment of EGF receptor ligand expression in gastric carcinoma and in lesional skin of paraneoplastic acanthosis nigricans: a case report

E. Moreno-Artero, E. Querol, M. Ivars, I. Sola, R. Pío, A. España

(6)

e302 EGFRI‐induced papulopustular rosacea‐like rash successfully treated with topical ivermectin S. Käser, C. Ruini, M. Ezmerli, T. von Braunmühl, D. Hartmann, T. Ruzicka, M. Reinholz

e304 Unusual scrotal and penile ulcerations together with palmar‐plantar erythrodysesthesia syndrome in a patient with metastatic colon carcinoma treated with capecitabine

S. Ljubojevic Hadzavdic, D. Stulhofer Buzina, I. Murtezani, M. Skerlev 1076 FORTHCOMING EVENTS

1077 ANNOUNCEMENT

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

Major research areas of the Faculty include museums as new places for adult learning, development of the profession of adult educators, second chance schooling, guidance

The decision on which direction to take lies entirely on the researcher, though it may be strongly influenced by the other components of the research project, such as the

By examining the factors, features, and elements associated with effective teacher professional develop- ment, this paper seeks to enhance understanding the concepts of

Usually hormones that increase cyclic AMP levels in the cell interact with their receptor protein in the plasma membrane and activate adenyl cyclase.. Substantial amounts of

In summary, although the majority of countries do have a specific legislation on sunbed use, surveillance market inspec- tions reveal that compliance is poor for the most

Introduction Sunbed use has been signi fi cantly associated with increased risk of melanoma and non-melanoma skin cancer (NMSC), but its relationship with melanoma ’ s risk factors

These data have public health relevance for Figure 4 Geographic particularities of sunbed use in Europe: Iberian particularity , prevalence of ever use was 10 times higher in Spain

Editors of the IBVS decided to use an OpenAIRE grant for the renewal of the journal, and keeping some key features, abandoning certain enhanced functions, and gaining some